The ASCO 2018 Fertility preservation in patients with cancer clinical practice guidelines include information on the specific risks to fertility based on each cancer therapy and also makes key recommendations.r
Risks to fertility based on treatment
Access the following the ASCO guidelines to review the risk of infertility based on each therapy. The tables represent a compilation of clinical experience and published data about the effect of common cancer treatments.r
- Discuss fertility preservation with ALL patients of reproductive age if infertility is a potential risk of therapy.
- Refer patients who express an interest in fertility preservation (and patients who are ambivalent) to reproductive specialists.
- Address fertility preservation as early as possible, before treatment starts.
- Document fertility preservation discussions in the medical record.
- Answer basic questions about whether fertility preservation may have an impact on successful cancer treatment.
- Refer patients to psychosocial providers if they experience distress about potential infertility.
- Encourage patients to participate in registries and clinical studies.
Fertility preservations options
Currently sperm, embryo and oocyte cryopreservation are considered standard practice.rrr Any other methods are considered investigational, and should be provided by clinicians with the necessary expertise.